Live Breaking News & Updates on Fulcrum Therapeutics Inc

Stay updated with breaking news from Fulcrum therapeutics inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Head to Head Comparison: Fulcrum Therapeutics (NASDAQ:FULC) vs. Cytokinetics (NASDAQ:CYTK)

Cytokinetics (NASDAQ:CYTK – Get Free Report) and Fulcrum Therapeutics (NASDAQ:FULC – Get Free Report) are both medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their institutional ownership, dividends, risk, earnings, profitability, analyst recommendations and valuation. Analyst Ratings This is a breakdown of current recommendations […] ....

United Kingdom , United States , South San Francisco , Acceleron Pharma Inc , Fulcrum Therapeutics Inc , Cytokinetics Incorporated , Myokardia Inc , Ji Xing Pharmaceuticals , Get Free Report , Fulcrum Therapeutics , Given Fulcrum Therapeutic , Fulcrum Therapeutic , Acceleron Pharma , Cytokinetics Daily ,

Fulcrum Therapeutics, Inc. Forecasted to Post FY2024 Earnings of ($0.78) Per Share (NASDAQ:FULC)

Fulcrum Therapeutics, Inc. (NASDAQ:FULC – Free Report) – Equities researchers at Cantor Fitzgerald issued their FY2024 EPS estimates for shares of Fulcrum Therapeutics in a note issued to investors on Monday, May 20th. Cantor Fitzgerald analyst K. Kluska forecasts that the company will earn ($0.78) per share for the year. Cantor Fitzgerald currently has a […] ....

United States , Piper Sandler , Greg Tourangeau , Goldman Sachs Group , Capital Management , Royal Bank , Fulcrum Therapeutics Company Profile , Cantor Fitzgerald , Fulcrum Therapeutics Inc , Fulcrum Therapeutics , Free Report , Fulcrum Therapeutic , Get Free Report , Point Capital , Fulcrum Therapeutics Daily ,

Fulcrum Therapeutics Sees Unusually Large Options Volume (NASDAQ:FULC)

Fulcrum Therapeutics, Inc. (NASDAQ:FULC – Get Free Report) was the target of unusually large options trading on Tuesday. Stock investors bought 9,544 call options on the company. This represents an increase of approximately 867% compared to the typical volume of 987 call options. Fulcrum Therapeutics Stock Down 0.8 % FULC stock opened at $7.64 on […] ....

United States , Piper Sandler , Greg Tourangeau , Sg Americas Securities , Fulcrum Therapeutics Inc , Vanguard Group Inc , Fulcrum Therapeutics Company Profile , Cantor Fitzgerald , Mirae Asset Global Investments Co , Securities Exchange Commission , Royal Bank , Fulcrum Therapeutics , Get Free Report , Therapeutics Stock Down , Exchange Commission , Street Group , Point Capital , Mirae Asset Global Investments , Fulcrum Therapeutics Daily ,

Investors Purchase High Volume of Fulcrum Therapeutics Call Options (NASDAQ:FULC)

Fulcrum Therapeutics, Inc. (NASDAQ:FULC – Get Free Report) was the target of unusually large options trading activity on Tuesday. Traders bought 9,544 call options on the stock. This represents an increase of 867% compared to the average daily volume of 987 call options. Insider Buying and Selling In other Fulcrum Therapeutics news, VP Greg Tourangeau […] ....

United States , Greg Tourangeau , Goldman Sachs Group , Fulcrum Therapeutics Inc , Royal Bank , Cantor Fitzgerald , China Universal Asset Management Co , Sg Americas Securities , Fulcrum Therapeutics Company Profile , Capstone Investment Advisors , Brown Wealth Management , Fulcrum Therapeutics , Get Free Report , Universal Asset Management , Investment Advisors , Wealth Management , Therapeutics Trading Down , Fulcrum Therapeutics Daily ,

Leerink Partnrs Analysts Boost Earnings Estimates for Fulcrum Therapeutics, Inc. (NASDAQ:FULC)

Fulcrum Therapeutics, Inc. (NASDAQ:FULC – Free Report) – Leerink Partnrs upped their Q2 2024 earnings per share (EPS) estimates for shares of Fulcrum Therapeutics in a report released on Monday, May 13th. Leerink Partnrs analyst J. Schwartz now anticipates that the company will post earnings per share of $0.74 for the quarter, up from their […] ....

United States , Piper Sandler , Leerink Partnrs , Greg Tourangeau , Goldman Sachs Group , Vanguard Group Inc , Royal Bank , Capstone Investment Advisors , Sg Americas Securities , Fulcrum Therapeutics Inc , China Universal Asset Management Co , Securities Exchange Commission , Fulcrum Therapeutics Company Profile , Brown Wealth Management , Fulcrum Therapeutics , Free Report , Fulcrum Therapeutic , Get Free Report , Therapeutics Trading Down , Exchange Commission , Universal Asset Management , Investment Advisors , Fulcrum Therapeutics Daily ,